Ruolin Wu

586 total citations
16 papers, 449 citations indexed

About

Ruolin Wu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Ruolin Wu has authored 16 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Ruolin Wu's work include RNA modifications and cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). Ruolin Wu is often cited by papers focused on RNA modifications and cancer (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). Ruolin Wu collaborates with scholars based in China, Germany and United States. Ruolin Wu's co-authors include Lei Huang, Aman Xu, Hongchuan Zhao, Xiaoping Geng, Guobin Wang, Fan Huang, Xinghua Zhang, Mohammed Abba, Jing Ke and Xiaojun Yu and has published in prestigious journals such as Scientific Reports, Medicine and Applied Clay Science.

In The Last Decade

Ruolin Wu

15 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruolin Wu China	9	203	138	115	84	78	16	449
Sakiko Sanada Japan	12	162 0.8×	201 1.5×	103 0.9×	125 1.5×	70 0.9×	29	501
Guojun Hou China	10	268 1.3×	73 0.5×	172 1.5×	44 0.5×	64 0.8×	15	427
Chun-Ying Qu China	14	271 1.3×	104 0.8×	152 1.3×	62 0.7×	41 0.5×	25	563
Hulin Chang China	14	277 1.4×	83 0.6×	177 1.5×	52 0.6×	75 1.0×	26	525
Xu–Ting Zhi China	12	232 1.1×	143 1.0×	189 1.6×	135 1.6×	99 1.3×	31	543
Eunsun Jung South Korea	13	228 1.1×	110 0.8×	102 0.9×	82 1.0×	42 0.5×	40	504
Liting Lu China	11	266 1.3×	108 0.8×	114 1.0×	34 0.4×	43 0.6×	23	426
Xiaoju Shi China	13	126 0.6×	128 0.9×	69 0.6×	77 0.9×	89 1.1×	35	415
Guang-Zhen Yang China	13	311 1.5×	105 0.8×	127 1.1×	79 0.9×	29 0.4×	22	501
Yifei Mu China	14	228 1.1×	140 1.0×	133 1.2×	43 0.5×	35 0.4×	27	457

Countries citing papers authored by Ruolin Wu

Since Specialization

Citations

This map shows the geographic impact of Ruolin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Wu more than expected).

Fields of papers citing papers by Ruolin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruolin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Wu. The network helps show where Ruolin Wu may publish in the future.

Co-authorship network of co-authors of Ruolin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruolin Wu. A scholar is included among the top collaborators of Ruolin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruolin Wu. Ruolin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wang, Shouwen, Qi Guo, Ruolin Wu, et al.. (2025). High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients. BMC Gastroenterology. 25(1). 33–33.

Wang, Lianzi, et al.. (2024). Lipopolysaccharide promotes cancer cell migration and invasion through METTL3/PI3K/AKT signaling in human cholangiocarcinoma. Heliyon. 10(8). e29683–e29683. 12 indexed citations

Wang, Haibo, Shouwen Wang, Liu Deng, et al.. (2023). Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma. Functional & Integrative Genomics. 23(1). 56–56. 5 indexed citations

Fang, Yuan, et al.. (2023). Is percutaneous drainage better than endoscopic drainage in the management of patients with malignant obstructive jaundice? A meta-analysis of RCTs. Frontiers in Oncology. 13. 1105728–1105728. 4 indexed citations

Wang, Wei, Tao Meng, Guoxing Wang, et al.. (2023). Construction and validation of a immune-related prognostic gene DHRS1 in hepatocellular carcinoma based on bioinformatic analysis. Medicine. 102(42). e35268–e35268. 2 indexed citations

Wang, Shouwen, Hongchuan Zhao, Guobin Wang, et al.. (2023). High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients. Scandinavian Journal of Gastroenterology. 58(6). 643–648. 3 indexed citations

Wu, Ruolin, Fan Huang, Guobin Wang, et al.. (2022). Liver Transplantation in Acute-on-Chronic Liver Failure: Excellent Outcome and Difficult Posttransplant Course. Frontiers in Surgery. 9. 914611–914611. 8 indexed citations

Yu, Xiaojun, Xinghua Zhang, Ruolin Wu, et al.. (2021). Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1/p21 signaling. Journal of Cell Communication and Signaling. 16(2). 179–190. 9 indexed citations

Wang, Guobin, Fan Huang, Rong Qin, et al.. (2021). Pretransplant use of toripalimab for hepatocellular carcinoma resulting in fatal acute hepatic necrosis in the immediate postoperative period. Transplant Immunology. 66. 101386–101386. 52 indexed citations

10.

Sakr, Mahmoud A.S., Mohamed G. A. Mohamed, Ruolin Wu, et al.. (2020). Development of bentonite-gelatin nanocomposite hybrid hydrogels for tissue engineering. Applied Clay Science. 199. 105860–105860. 20 indexed citations

11.

Wu, Ruolin, Anja Schmaus, Julia Philipp, et al.. (2018). Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells. Scientific Reports. 8(1). 14913–14913. 26 indexed citations

12.

Ke, Jing, et al.. (2018). Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.. PubMed. 10(12). 3887–3910. 27 indexed citations

13.

Wu, Ruolin, Lei Huang, Hongchuan Zhao, & Xiaoping Geng. (2016). Hyaluronic acid in digestive cancers. Journal of Cancer Research and Clinical Oncology. 143(1). 1–16. 42 indexed citations

14.

Zhao, Hongchuan, Ruolin Wu, Fubao Liu, et al.. (2016). A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma. HPB. 18(11). 943–949. 17 indexed citations

15.

Huang, Lei, Ruolin Wu, & Aman Xu. (2015). Epithelial-mesenchymal transition in gastric cancer.. PubMed. 7(11). 2141–58. 221 indexed citations

16.

Wu, Ruolin, Xiaoping Geng, Hongchuan Zhao, et al.. (2013). Mesohepatectomy for centrally located large hepatocellular carcinoma. Zhonghua putong waike zazhi. 28(3). 200–204. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact